SCHEMBL5187445

SCHEMBL5187445

COc1ccc(NS(=O)(=O)c2ccccc2NC(=O)c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SNCA P37840 1/20 0.59
▸ CCR8 P51685 1/20 0.59
▸ MEN1 O00255 6/20 0.58
▸ KMT2A Q03164 6/20 0.58
▸ MAPT P10636 5/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ HTT P42858 3/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ NPC1 O15118 3/20 0.56
▸ GAA P10253 1/20 0.55
▸ TUBB4A P04350 1/20 0.54
▸ TUBB P07437 1/20 0.54
▸ TUBA3C P0DPH7 1/20 0.54
▸ TUBA1B P68363 1/20 0.54
▸ TUBA4A P68366 1/20 0.54
▸ TUBB4B P68371 1/20 0.54
▸ TUBB3 Q13509 1/20 0.54
▸ TUBB2A Q13885 1/20 0.54
▸ TUBB8 Q3ZCM7 1/20 0.54
▸ TUBA3E Q6PEY2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1340222 0.88 CCR8 (0.78) SNCACCR8MEN1KMT2AMAPT
SCHEMBL5188604 0.85 LMNA (0.68) CCR8MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5188667 0.83 CCR8 (0.63) SNCACCR8MEN1KMT2AMAPT
SCHEMBL5669631 0.80 GAA (0.61) SNCAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL2061754 0.79 ALOX5 (0.77) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL2633343 0.79 ALOX5 (0.77) MEN1KMT2AMAPTSMN1; SMN2HTT
Hydrochloric Acid SCHEMBL9423776 0.78 ALOX5 (0.75) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL13265822 0.78 LMNA (0.58) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL1337665 0.78 CCR8 (0.89) CCR8MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1339700 0.77 CCR8 (0.93) CCR8MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421057-A4 CHEMOTHERAPEUTIC AGENTS STARPHARMA PTY LTD (AU) 2007-03-14 — — EP claimed
US-20050038248-A1 Chemotherapeutic agents STARPHARMA PTY LTD (AU) 2005-02-17 — — US claimed
EP-1421057-A1 CHEMOTHERAPEUTIC AGENTS Starpharma Limited (AU) 2004-05-26 — — EP claimed
WO-2003018536-A1 CHEMOTHERAPEUTIC AGENTS STARPHARMA LIMITED (AU) 2003-03-06 — — WO claimed
EP-1421057-A4 CHEMOTHERAPEUTIC AGENTS STARPHARMA PTY LTD (AU) 2007-03-14 — — EP disclosed
US-20050038248-A1 Chemotherapeutic agents STARPHARMA PTY LTD (AU) 2005-02-17 — — US disclosed
EP-1421057-A1 CHEMOTHERAPEUTIC AGENTS Starpharma Limited (AU) 2004-05-26 — — EP disclosed
WO-2003018536-A1 CHEMOTHERAPEUTIC AGENTS STARPHARMA LIMITED (AU) 2003-03-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038248-A1 Chemotherapeutic agents MKI67, PCNA, MCL1 SNCA 4371/4885CCR8 511/4885MEN1 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback